• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

以色列国家卫生服务清单更新中的财务风险分担:利益相关者的感知利益。

Financial risk-sharing in updating the National List of Health Services in Israel: stakeholders' perceived interests.

机构信息

Department of Health Systems Management, Faculty of Health Sciences and Guilford-Glazer Faculty of Business and Management, Ben-Gurion University of Negev, Beer-Sheva, Israel.

出版信息

Value Health. 2012 Jul-Aug;15(5):737-42. doi: 10.1016/j.jval.2012.01.007. Epub 2012 Apr 11.

DOI:10.1016/j.jval.2012.01.007
PMID:22867784
Abstract

OBJECTIVES

Risk-sharing is being considered by many health care systems to address the financial risk associated with the adoption of new technologies. We explored major stakeholders' views toward the potential implementation of a financial risk-sharing mechanism regarding budget-impact estimates for adding new technologies to the Israeli National List of Health Services. According to our proposed scheme, health plans will be partially compensated by technology sponsors if the actual use of a technology is substantially higher than what was projected and health plans will refund the government for budgets that were not fully utilized.

METHODS

By using a semi-structured protocol, we interviewed major stakeholders involved in the process of updating the National List of Health Services (N = 31). We inquired into participants' views toward our proposed risk-sharing mechanism, whether the proposed scheme would achieve its purpose, its feasibility of implementation, and their opinion on the other stakeholders' incentives.

RESULTS

Participants' considerations were classified into four main areas: financial, administrative/managerial, impact on patients' health, and influence on public image. Most participants agreed that the conceptual risk-sharing scheme will improve the accuracy of early budget estimates and were in favor of the proposed scheme, although Ministry of Finance officials tended to object to it.

CONCLUSIONS

The successful implementation of risk-sharing schemes depends mainly on their perception as a win-win situation by all stakeholders. The perception exposed by our participants that risk-sharing can be a tool for improving the accuracy of early budget-impact estimates and the challenges pointed by them are relevant to other health care systems also and should be considered when implementing similar schemes.

摘要

目的

许多医疗保健系统正在考虑风险分担,以解决采用新技术所带来的财务风险。我们探讨了主要利益相关者对潜在实施财务风险分担机制的看法,该机制涉及对以色列国家卫生服务清单中新技术的预算影响估计。根据我们提出的方案,如果一种技术的实际使用量大大高于预期,健康计划将部分得到技术赞助商的补偿,而如果健康计划未充分利用预算,则将向政府退还资金。

方法

通过使用半结构化方案,我们采访了参与更新国家卫生服务清单(N = 31)过程的主要利益相关者。我们询问了参与者对我们提出的风险分担机制的看法、该方案是否能够实现其目的、实施的可行性以及他们对其他利益相关者激励措施的看法。

结果

参与者的考虑因素分为四个主要领域:财务、行政/管理、对患者健康的影响以及对公共形象的影响。大多数参与者认为,概念性的风险分担方案将提高早期预算估计的准确性,并赞成该方案,尽管财政部官员倾向于反对。

结论

风险分担方案的成功实施主要取决于所有利益相关者将其视为双赢局面的看法。我们的参与者所暴露的风险分担可以是提高早期预算影响估计准确性的工具的观点,以及他们所指出的挑战,与其他医疗保健系统也相关,在实施类似方案时应予以考虑。

相似文献

1
Financial risk-sharing in updating the National List of Health Services in Israel: stakeholders' perceived interests.以色列国家卫生服务清单更新中的财务风险分担:利益相关者的感知利益。
Value Health. 2012 Jul-Aug;15(5):737-42. doi: 10.1016/j.jval.2012.01.007. Epub 2012 Apr 11.
2
Estimating the budget impact of new technologies added to the National List of Health Services in Israel: stakeholders' incentives for adopting a financial risk-sharing mechanism.估算新增至以色列国家医疗服务清单的新技术的预算影响:利益相关者采用财务风险分担机制的激励因素。
Health Policy. 2009 Jan;89(1):78-83. doi: 10.1016/j.healthpol.2008.05.006. Epub 2008 Jun 24.
3
Risk sharing or risk shifting? On the development of patient access schemes in the process of updating the national list of health services in Israel.风险分担还是风险转移?论以色列国家医疗服务清单更新过程中患者准入方案的发展
Expert Rev Pharmacoecon Outcomes Res. 2019 Dec;19(6):749-753. doi: 10.1080/14737167.2019.1702525. Epub 2019 Dec 11.
4
[Risk-sharing schemes: a new paradigm in adopting innovative pharmaceuticals].[风险分担计划:采用创新药物的新范式]
Harefuah. 2012 Jun;151(6):364-7, 376.
5
Year 2006 update of the Israel National List of Health Services.《2006年以色列国家卫生服务清单更新》
Isr Med Assoc J. 2006 Sep;8(9):595-600.
6
[Risk-sharing scheme in Israel--Kuvan as an allegory].[以色列的风险分担计划——库凡作为一个寓言]
Harefuah. 2012 Jun;151(6):362-3, 377, 376.
7
Impact of a financial risk-sharing scheme on budget-impact estimations: a game-theoretic approach.财务风险分担方案对预算影响估计的作用:一种博弈论方法。
Eur J Health Econ. 2014 Jun;15(5):553-61. doi: 10.1007/s10198-013-0544-6. Epub 2013 Dec 11.
8
Risk avoidance and missed opportunities in mental health reform: the case of Israel.心理健康改革中的风险规避与错失的机遇:以以色列为例
Int J Law Psychiatry. 2007 May-Jun;30(3):163-81. doi: 10.1016/j.ijlp.2007.03.001. Epub 2007 Apr 27.
9
Financing the package of services during the first decade of the national health insurance law in Israel: trends and issues.以色列国家健康保险法实施头十年期间服务套餐的融资:趋势与问题
Health Policy. 2008 Sep;87(3):273-84. doi: 10.1016/j.healthpol.2008.02.008. Epub 2008 Apr 18.
10
Healthcare reform implementation: stakeholders and their roles-the Israeli experience.医疗改革实施:利益相关者及其角色——以色列的经验
Health Policy. 2005 Jan;71(1):1-21. doi: 10.1016/j.healthpol.2004.05.001.

引用本文的文献

1
Stakeholder views of managed entry agreements: A literature review of national studies.利益相关者对有条件准入协议的看法:一项关于各国研究的文献综述
Health Policy Open. 2021 Jan 21;2:100032. doi: 10.1016/j.hpopen.2021.100032. eCollection 2021 Dec.
2
Country versus pharmaceutical company interests for hepatitis C treatment.国家利益与制药公司利益在丙型肝炎治疗上的冲突。
Health Care Manag Sci. 2022 Dec;25(4):725-749. doi: 10.1007/s10729-022-09607-2. Epub 2022 Aug 24.
3
Impact of a financial risk-sharing scheme on budget-impact estimations: a game-theoretic approach.
财务风险分担方案对预算影响估计的作用:一种博弈论方法。
Eur J Health Econ. 2014 Jun;15(5):553-61. doi: 10.1007/s10198-013-0544-6. Epub 2013 Dec 11.
4
Oncologists' and family physicians' views on value for money of cancer and congestive heart failure care.肿瘤学家和家庭医生对癌症和充血性心力衰竭治疗的性价比的看法。
Isr J Health Policy Res. 2013 Nov 18;2:44. doi: 10.1186/2045-4015-2-44. eCollection 2013.